Sign in Subscribe
News agencies

Analysis of the Global Diabetes Drug Delivery Market: Future Options for End-Users

Strategic Insights

— 1 min read

The global injectable and oral diabetes drug delivery market has experienced significant growth in recent years, with the injectable segment expected to remain the largest in terms of market share. The market is expected to be driven by the increasing prevalence of diabetes and the launch of new pipeline products. Key companies such as U x and IDegLira are planning to launch pipeline products between 2015 and 2020. Meanwhile, oral insulin and other needleless drug delivery systems, such as Omarigliptin (MK-3102), Metformin Fixed Dose Combination (FDC), and Dallresp (roflumilast), are expected to enter the market by the end of 2019.

Key Takeaways:

  • The global injectable drug delivery market was estimated to be $x billion in 2014, with diabetes injectables making up x% at $x billion.
  • The global oral drug delivery market was valued at $x billion in 2014, with oral diabetes drugs comprising x% ($x billion).
  • Injectable pens form the most attractive drug delivery sector in the diabetes drug market, with major companies planning to launch pipeline products between 2015 and 2020 (e.g., U x and IDegLira).
  • Oral insulin and other needleless drug delivery systems, such as Omarigliptin (MK-3102), Metformin Fixed Dose Combination (FDC), and Dallresp (roflumilast), are expected to enter the market by the end of 2019.
  • Insulin inhalers such as Afrezza from MannKind Corporation are expected to launch in Q1 2015, and insulin patches are under development and could become game changers in the diabetes drug delivery market.
  • In 2015, four major diabetes drugs will enter the US and European markets (Afrezza, Tanzeum, Xigduo XR, and Xultophy).
  • The global diabetes drug market can expect increased investment in the future, depending on the acceptance of inhalable diabetes drug delivery.

Statistics:

  • The global injectable drug delivery market was estimated to be $x billion in 2014.
  • Diabetes injectables made up x% of the market, valued at $x billion.
  • The global oral drug delivery market was valued at $x billion in 2014, with oral diabetes drugs comprising x%.
  • Four major diabetes drugs are expected to enter the US and European markets in 2015.

Sources:

  • [1] Frost & Sullivan, "Global Diabetes Drug Delivery Market 2015"
  • [2] Reportlinker, "Analysis of the Global Diabetes Drug Delivery Market 2015"
  • [3] PR Newswire, "Analysis of the Global Diabetes Drug Delivery Market: Future Options for End-Users"

Read more